Table of Contents

International Documents on Corporate Responsibility

International Documents on Corporate Responsibility

Edited by Stephen Tully

International Documents on Corporate Responsibility includes the principal international, regional and national instruments drafted by intergovernmental organisations or states as well as codes of conduct formulated by industry associations, trade unions and non-governmental organisations. The coverage includes the fields of human rights, international criminal and environmental law, labour standards, international trade, armed conflict, sustainable development, corruption, consumer protection and corporate governance. Each document is accompanied by a brief explanatory commentary outlining the historical origins of the instrument, the principal actors involved, controversial negotiation issues, applicable implementation procedure, and identifies further reference material.

Chapter 120: WHO: Ethical Criteria for Medicinal Drug Promotion, 1988

Edited by Stephen Tully

Subjects: law - academic, company and insolvency law, corporate law and governance

Extract

Commentary: The Ethical Criteria (WHA Resolution WHA41.17) identifies the roles and responsibilities of inter alia pharmaceutical manufacturers and distributors, employers of medical representatives and advertisers with respect to promoting medicinal drugs. The Appendix contains a sample drug information sheet: see further, WHO (1985), ‘Second Report of the WHO Expert Committee: The Use of Essential Drugs’, Technical Report Series No 722. Other tools include WHO (1999), ‘Guidelines for Drug Donations’, WHO Doc WHO/EDM/PAR/99.4 (2nd edn); WHO (2000), ‘Operational Principles for Good Pharmaceutical Procurement Supply and Marketing’, WHO Doc WHO/EDM/PAR/99.5. See also, the series of WHO Policy Perspectives on Medicines: No 2 on access to essential drugs (in preparation); No 3 concerning globalisation, TRIPS and access to pharmaceuticals, WHO Doc WHO/EDM/2001.2 (2001). See generally, WHO (2000), ‘Medicines Strategy: Framework for action in essential drugs and medicines policy’, 2000–2003, WHO Doc WHO/EDM/2000.1 which updated WHA Resolutions WHA39.27 (1986) and WHA21.41 (1968). See also, the Medical Lobby for Appropriate Marketing (MaLAM), the International Federation of Pharmaceutical Manufacturers’ Association (IFPMA) and www.who.int. Objective 2. The main objective of ethical criteria for medicinal drug promotion is to support and encourage the improvement of health care through the rational use of medicinal drugs. Applicability and Implementation of Criteria 4. These criteria constitute general principles for ethical standards which could be adapted by governments to national circumstances as appropriate to their political, economic, cultural, social, educational, scientific and technical situation, laws and regulations, disease profile, therapeutic traditions and the level of development of their health system. They...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information